You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Herombopag

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aplastic Anemia, Drug Effect Trial in Beijing (Herombopag + CsA, rhTPO combined with Herombopag + CsA)

Not yet recruiting
  • Aplastic Anemia
  • Drug Effect
  • Herombopag + CsA
  • rhTPO combined with Herombopag + CsA
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Adult Patients With Chronic Primary ITP, Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy Trial

Not yet recruiting
  • Adult Patients With Chronic Primary ITP
  • Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy
  • Herombopag Olamine Tablets
  • (no location specified)
Sep 28, 2023

Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Herombopag
  • Herombopag
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023

Immune Thrombocytopenia Trial (Herombopag)

Not yet recruiting
  • Immune Thrombocytopenia
  • Herombopag
  • (no location specified)
Jan 13, 2023

Aplastic Anemia, CSA, Drug Therapy Trial in Beijing (CsA+ATG+Herombopag, CsA+Herombopag)

Recruiting
  • Aplastic Anemia
  • +2 more
  • Beijing, China
    Peking union medical college hospital
Aug 20, 2023

Non Severe Aplastic Anemia, Untreated Trial in China (Herombopag)

Recruiting
  • Non Severe Aplastic Anemia
  • Untreated
  • Herombopag
  • Tangshan, Hebei, China
  • +3 more
Dec 14, 2022

Tumor Therapy-related Thrombocytopenia Trial (TPO-RA (Herombopag), TPO-RA (Herombopag) and rhTPO(Recombinant human

Not yet recruiting
  • Tumor Therapy-related Thrombocytopenia
  • TPO-RA (Herombopag)
  • TPO-RA (Herombopag) and rhTPO(Recombinant human thrombopoietin)
  • (no location specified)
Apr 27, 2022

Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

Recruiting
  • Immune Thrombocytopenia
  • Suzhou, Jiangsu, China
    Jie Yin
Apr 19, 2022

Malignant Tumors of the Digestive System, Trombocitopenia Trial in Wuhan (Hetrombopag Olamine)

Recruiting
  • Malignant Tumors of the Digestive System
  • Trombocitopenia
  • Hetrombopag Olamine
  • Wuhan, Hubei, China
    xianglin Yuan
Oct 7, 2022

NSCLC Trial (herombopag olamine tablets)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • herombopag olamine tablets
  • (no location specified)
Feb 14, 2022

Herombopag in Treatment of Thrombocytopenia Related Diseases in

Recruiting
  • Carcinoma;Blood
  • Herombopag
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Nov 18, 2021

Hepatopathy Trial in Shanghai (Hetrombopag, Placebo)

Recruiting
  • Hepatopathy
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 7, 2022

Immune Thrombocytopenia, Autoantibodies, Evan Syndrome Trial in Tianjin (Avatrombopag)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 3, 2021

Tumor Chemo-related Thrombocytopenia Trial in Taiyuan (Herombopag Olamine)

Not yet recruiting
  • Tumor Chemotherapy-related Thrombocytopenia
  • Herombopag Olamine
  • Taiyuan, Shanxi, China
    The second hospital of Shanxi Medical University
Dec 6, 2021

Healthy Trial in Suzhou (Hetrombopag Olamine)

Completed
  • Healthy
  • Hetrombopag Olamine
  • Suzhou, Jiangsu, China
    The first affiliated hospital of Suzhou university
May 6, 2020

Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)

Recruiting
  • Chemotherapy-induced Thrombocytopenia
  • Avatrombopag
  • Tianjin, Tianjin, China
    Chinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023

Immune Thrombocytopenia Trial in Changsha (Hetrombopag Olamine)

Completed
  • Immune Thrombocytopenia
  • Hetrombopag Olamine
  • Changsha, Hunan, China
    The third xiangya hospital Hospital,of central south university
May 5, 2019